Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Oka M, et al. Glidobactins A, B and C, new antitumor antibiotics. I. Production, isolation, chemical properties and biological activity. J. Antibiot. 41: 1331-1337, 1988. PubMed: 3142840
Oka M, et al. Glidobactins A, B and C, new antitumor antibiotics. II. Structure elucidation. J. Antibiot. 41: 1338-1350, 1988. PubMed: 3142841
Numata K, et al. Enzymatic formation of glidobactamine: a peptide nucleus of glidobactins A, B and C, new lipopeptide antitumor antibiotics. J. Antibiot. 41: 1351-1357, 1988. PubMed: 3142842
Numata K, et al. Enhanced production of the minor components of glidobactins in Polyangium brachysporum. J. Antibiot. 41: 1358-1365, 1988. PubMed: 3142843
Oka M, et al. Glidobactins D, E, F, G and H: minor components of the antitumor antibiotic glidobactin. J. Antibiot. 41: 1906-1909, 1988. PubMed: 3145259
Tomita K, et al. Peptide antibiotics. US Patent 4,692,510 dated Sep 8 1987
